These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 53067)

  • 1. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix.
    Singer A; Shelton J; Hill S; Potter C
    Br J Obstet Gynaecol; 1975 Oct; 82(10):820-5. PubMed ID: 53067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
    Flavell DJ; Singer A; Potter CW
    Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
    Flavell DJ; Potter CW
    Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoantigens ABO in cervical neoplasia.
    Stafl A; Mattingly RF
    Gynecol Oncol; 1972 Nov; 1(1):26-35. PubMed ID: 4669441
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.
    Shelton JB; Potter CW; Carr I
    Br J Cancer; 1975 May; 31(5):528-34. PubMed ID: 50855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth.
    Flavell DJ; Goepel J; Potter CW; Carr I
    Br J Cancer; 1978 May; 37(5):818-26. PubMed ID: 77674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dinitrochlorobenzene reactivity of women with cancer of the ovary, cervix and corpus uteri.
    Khoo SK; Mackay E; Daunter B
    Int J Gynaecol Obstet; 1978 Jul-1979 Aug; 17(1):58-62. PubMed ID: 39839
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of dysplasia and corcinoma in situ of the cervix uteri].
    Pieroni G; Bonardi L; Ottaviano M; Marchionni M
    Minerva Ginecol; 1975 May; 27(5):393-403. PubMed ID: 1134689
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dysplasia and carcinoma in situ of the uterine portio. Clinical, histopathological and histochemical findings].
    Bertaglia A; De Gaetani CF; Trentini GP
    Arch De Vecchi Anat Patol; 1974 Aug; 60(1):29-41. PubMed ID: 4470381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dysplasia and carcinoma in situ of the cervix uteri].
    Vooys GP
    Ned Tijdschr Geneeskd; 1975 Mar; 119(9):358-66. PubMed ID: 1134600
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphology and histogenesis of dysplasias of the cervix uteri].
    Iakovleva IA; Chernyĭ AP
    Arkh Patol; 1985; 47(11):32-7. PubMed ID: 4091694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Papilloma virus-induced changes in the uterine cervix. Histo- and cytologic and epidemiologic findings].
    Barten G; Rohde E; Beust M
    Zentralbl Gynakol; 1985; 107(10):634-9. PubMed ID: 2990121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management and natural history of severe dysplasia and carcinoma in situ of the uterine cervix.
    Gad C
    Br J Obstet Gynaecol; 1976 Jul; 83(7):554-9. PubMed ID: 952784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity in carcinoma of the uterine cervix.
    Lambert B; Boushira M; Pelletier M; Montplaisir S
    Gynecol Oncol; 1984 Mar; 17(3):394-5. PubMed ID: 6608476
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of cryosurgery for dysplasia and carcinoma in situ of the uterine cervix.
    Elmfors B; Stormby N
    Br J Obstet Gynaecol; 1979 Dec; 86(12):917-21. PubMed ID: 526449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of epithelial-specific antigen for cytological diagnosis of glandular lesions in the uterine cervix.
    Matsui N; Kajiwara H; Morishita A; Iida T; Nakazawa K; Miyazawa M; Mikami M; Ogawa T; Nakamura N; Sato S
    Pathol Int; 2016 May; 66(5):305-8. PubMed ID: 26792568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.